MTOR and metabolic syndrome: mTOR-S6k is one of the most common deregulated pathways in various cancers, and overactivation of the mTOR pathway is closely related to cell growth, metabolism, aging, insulin resistance and obesity, of which are the most common risk factors resulting in MetS [15, 16].